Friday’s Top Analyst Upgrades and Downgrades: AMC Entertainment, APA, Chewy, FirstSolar, Marathon Oil, Match, Meta, Pioneer Natural Resources, Toast and More

The futures were trading lower, as we get ready to end a rollercoaster week for the stock market. All the major indexes finished a volatile Thursday higher, with the Nasdaq leading the way, up over 1%. While Federal Reserve Chair Powell raised rates by 25 basis points on Wednesday, many took his prepared comments and his press conference follow-up as […]

» Read more

Evergrande restructuring is a warning to China’s other creditors

video China anticipates being isolated from the global order: Brig. Gen. Rob Spalding Retired U.S. Air Force Brig. Gen. Rob Spalding reacts to China issuing a warning against global rate hikes on ‘Cavuto: Coast to Coast.’ China Evergrande has finally laid out a debt-restructuring plan for its offshore creditors. The pain for its long-suffering debt investors, however, isn’t over yet. […]

» Read more

Bitcoin Dominance Surged to 47% in March as Crypto Market Rallied

Bitcoin dominance, the ratio of Bitcoin’s market cap to the overall crypto market, surged in March amid the recent banking crisis that saw three central US banks collapse in one week. The move coincides with a surge in the price of Bitcoin, which has also hit a nine-month high. Bitcoin Price Breaks Through $28,000 Amid Banking Crisis Bitcoin jumped above $28,000, […]

» Read more

The Fed just made its choice. It could have serious ramifications

The US Federal Reserve was caught within the proverbial “rock and a hard place,” forced to choose between maintaining its fight against inflation or easing the pressure on a regional banking sector in crisis. It has chosen to prioritise the year-long struggle to get inflation under control. After the two-day meeting of its Open Market Committee, which sets monetary policy […]

» Read more

89bio: Phase 2b ENLIVEN Trial Of Pegozafermin In Patients With NASH Meets Primary Goals

89bio, Inc. (ETNB), a clinical-stage biopharmaceutical company focused on liver and cardiometabolic diseases, announced Wednesday positive topline data from the Phase 2b ENLIVEN trial evaluating treatment with pegozafermin in patients with nonalcoholic steatohepatitis or NASH. The company said the positive data from this rigorous trial supports advancement to Phase 3 trial. In pre-market activity on Nasdaq, 89bio shares were gaining […]

» Read more

UK inflation rate unexpectedly rises to 10.4% in February

video FOX Business Flash top headlines for March 21 Check out what’s clicking on FoxBusiness.com On the day that the U.S. Federal Reserve will issue a decision on interest rates, policymakers in Britain are also grappling with rising inflation and interest rate decisions. British inflation unexpectedly rose to 10.4% in February, pushed up by higher food prices and pricier drinks […]

» Read more

Treasuries Give Back Ground Following Last Friday's Rally

After moving sharply higher in the previous session, treasuries showed a notable move back to the downside during trading on Monday. Bond prices came under pressure in morning trading and remained firmly negative throughout the afternoon. Subsequently, the yield on the benchmark ten-year note, which moves opposite of its price, climbed 8.6 basis points to 3.481 percent. The ten-year yield […]

» Read more

UBS to buy Credit Suisse in historic $3b deal to end crisis

Swiss banking giant UBS agreed to buy Credit Suisse in a historic, government-brokered deal aimed at containing a crisis of confidence that threatened to spread across global financial markets. The Swiss bank is paying more than $US2 billion ($3 billion) for its rival, according to people with knowledge of the matter. It will be an all-share deal and priced at […]

» Read more

Nervous wait ahead of US Federal Reserve next move

Bond investors battered by the wildest swings in decades are hunkering down for their next big test: navigating the United States Federal Reserve’s response to the mounting financial instability that threatens to derail its fight against inflation. No matter what the central bank does, investors face more pain after volatility surged to levels not seen since the 2008 financial crisis. […]

» Read more
1 2 3 176